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Tbe alpha/beta (type I) interferon-inducible human MxA protein confen resistance to vesicular stomatitis 
virus (VSV) and inßuenza A virus in MxA·transfected mouse 3T3 cells (31'3/MxA). We investigated the 
inhibitory etfects of the MxA protein on measles virus (MV) and VSV in the human monocytic cell line U937. 
In transfected U937 clones which constitutively express MxA (U937/MxA), the release of infectious MV and 
VSV was reduced approximately 100-fold in comparison with control titers. Transcription of VSV was 
inhibited similar to that observed for 3T3/MxA cells, whereas no ditference was detected for MV in the rates 
of transcripdon or the Ievels of MV -specific mRNAs. In contrast, analysis of MV protein expression by 
immunoßuorescence and immunoprecipitation revealed a significant reduction in the synthesis of MV 
glycoproteins FandHin U937/MxA cells. These data demoostrate a virus-specific etfect of MxA which may, 
in the case of MV, contribute to the establishment of a penistent infection in human monocytic cells. 
The interaction of measles virus (MV) with peripheral 
blood mononuclear cells (PBMCs) in acute measles is of 
pathogenetic importance since this virus not only replicates 
in these different cell populations (19, 30, 45) but also alters 
their function (25). In particular, the immunosuppression 
that accompanies acute measles, and contributes to oppor-
tunistic infections which account for most of the morbidity 
and mortality associated with measles, is of interest (8, 25). 
It is evident that these effects are in part dependent on the 
replication strategy of the virus as weil as on host factors. So 
far, the mechanisms by which MV interferes with PBMC 
functions are unknown. · 
During acute measles, MV can be isolated from PBMC 
fractions of patients (22, 37), whereas after disease recovery 
infectious MV has disappeared (22, 27, 37, 38). Only occa-
sionally is it possible to demoostrate the presence of MV in 
PBMCs of healthy donors who have previously experienced 
acute MV infections, suggesting a state of viral persistence 
(3, 13, 36). In tissue culture experiments, productive as weil 
as silent MV infections have been observed in PBMCs, 
depending on the activation stage of the ceils, providing 
evidence of a direct influence of cellular factors in MV 
replication (6, 25). In lymphocytes, for example, MV can 
replicate only after these cells have been stimulated by a 
mitogen, whereas in unstimulated ceils MV RNA persists. 
Subsequent Stimulation of infected lymphocytes Ieads to 
viral replication without lymphocyte proliferation and differ-
entiation (6, 8, 19, 25). For permanent celllines of lympho-
cytic origin, a lytic infection, as weil as the establishment of 
persistent infections, has been described, allowing the inves-
tigation of cellular factors contributing to MV persistence (5, 
9, 21). 
The observed downregulation of MV multiplication in 
PBMCs appears to be mediated by cytokines that are in-
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duced upon infection. In particular, type I interferon (IFN) 
has been shown tobe released from MV-infected PBMCs 
(20) and, more recently, to interfere with MV replication in 
these cells (24). In response to IFN, a variety of IFN-
inducible proteins with different antiviral activities are pro-
duced, but it is not clear which of these interferes with MV 
gene expression. In other virus-host cell systems, the human 
cytoplasmic MxA protein, an IFN-inducible protein, has 
been shown to restriet the replication of vesicular Stomatitis 
virus (VSV) and influenza A virus in stably transfected 
mouse 3T3 cells. In the case of VSV infection, a downreg-
ulation of primary transcription occurred, whereas a later 
step of viral replication was blocked in influenza virus-
infected cells (32, 43). 
Since the MxA protein has been shown t~ be expressed to 
high Ievels in monocytes following IFN treatment in vivo 
(44), we analyzed the in vitro replication of MV in compar-
ison with that of VSV in an MxA-expressing stably trans-
fected human mononuclear cell line, U937. Production of 
infectious virus particles was blocked by approximately 2 
Iogs for MV and VSV in MxA-expressing U937 cells com-
pared with nonexpressing cells. However, in contrast to 
VSV, MV -specific transcription was not altered in the pres-
ence of MxA. Analysis of protein expression showed the 
synthesis of MV -specific glycoproteins F and H to be 
inhibited, indicating that the mechanism of MxA-mediated 
restriction of MV gene expression occurs at a posttranscrip-
tionallevel. These data suggest that MxA-dependent specific 
inhibition of glycoprotein expression may contribute to the 
establishrnent of measles virus persistence in PBMCs. 
MATERIALS AND METHODS 
Celllines, viruses, IFNs, and antibodies. The human histo-
cytic Iymphoma ceil line U937 was grown in RPMI 1640 
containing 10% fetal calf serum, 2.0 g of NaHC03 per Iiter, 
0.1 g of penicillin per Iiter, and 0.1 g of streptomycin per 
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Iiter. For the human B-eeil line BJAB, this medium con-
tained in addition 1 mM sodium pyruvate, 1 x nonessential 
amino acids, 1 x Eagle basal medium vitamins, and 2 mM 
L-glutamine (all from Seromed). Vero (African green mon-
key kidney) cells were grown in minimal essential medium 
supplemented with 5% fetal calf serum. Stocks of measles 
virus, Edmonston strain, were prepared from infected Vero 
cells. Stocks of VSV, serotype Indiana, were prepared from 
infected Swiss mouse 3T3 cells as previously described (12). 
Recombinant human alpha interferon (IFN-a) and beta in-
terferon (IFN-ß) were obtained from Merck. The p68 anti-
body was a generaus gift from G. Barber. For immunopre-
cipitation, a measles-specific human serum with a hem-
agglutination inhibition titer of 1:1,024 was used. 
Plasmid construction and transfection. The entire coding 
sequence of the human MxA genewas excised by a Smal 
digest of pHG327/MxA (1). The 2.2-kb MxA fragmentwas 
cloned into the blunt-ended BamHl site of the expression 
vector pHß APr-1-neo (15) containing the human ß-actin 
promoter, generating the vector pHß APr-1-neo/MxA. 
U937 cells were transfected with this construct by the 
lipofectin method in accordance with the manufacturer's 
instructions (GIBCO/BRL). For selection, cells were cul-
tured in the presence of 1 mg of G418 permland examined 
for MxA expression after 4 weeks by immunoftuorescence. 
Transfectants were cloned by limiting dilution and assayed 
for MxA expression by immunoftuorescence and Western 
blot (immunoblot) analysis. 
Titration. A total of 106 U937 cells or U937 /MxA trans-
fectants were infected with 107 PFU of MV or VSV at 37°C 
for 1 h. The virus inoculum was removed by centrifugation, 
and infected cells were incubated at 37°C for the time 
intervals indicated. Tenfold dilutions of the supematants 
were analyzed on Vero cells by endpoint titration after 3 or 
4 days of incubation. 
RNA analysis. A total of 107 U937 cells or U937/MxA 
transfectants were infected with MV at a multiplicity of 
infection (MOl) of 1 for 4 days. Cells were lysed in 4 M 
guanidinium isothiocyanate buffer, and RNA was purified by 
centrifugation through a CsCl cushion as described previ-
ously (11). A total of 30 JJ.g of total RNA samples and 1 Jl.g of 
pA + Vero control RNA, which was enriched by 1 cycle of 
oligo(dT)-cellulose chromatography (Sigma), was analyzed 
by quantitative Northem (RNA) blot assay as described 
earlier (39). Briefty, RNA was separated on a 1.5% agarase 
gel containing formaldehyde. After blotting onto nitrocellu-
lose, filters were cut into strips and hybridized to strand-
specific, [32P)CTP-labelled RNA probes specific for the MV 
genes N, P, M, F, and H. The concentrations of the added 
synthetic standard RNAs were as follows: N, 13 fmol; P, 7 
fmol; M, 7 fmol; F, 10 fmol; and H, 5 fmol. 
For the in vivo [32P)Pi labelling of MV-specific RNA 
synthesis, 107 cells of U937/MxA clones 5, 6, and 8 were 
infected with MV at an MOl of 1 for 20 h. Cells were starved 
for 1 hin phosphate-free medium (ICN-Flow) containing 20 
JJ.g of actinomycin D per ml before being Iabelied with 0.6 
mCi of [32P]Pi in the presence of actinomycin D (10 JJ.g/ml) 
for 7 h. RNA was prepared as described above, separated on 
a 1.5% agarose gel containing formaldehyde, transferred to a 
nitrocellulose filter, and analyzed by autoradiography. 
For the pulse-chase experiment, 3 x 107 U937 cells, 3 x 
107 U937/MxA clone 5 cells, and 6 x 106 Vero cells were 
infected with MV at an MOl of 1. Cells were Iabelied after 20 
h, following 1 h of phosphate starvation, with 1.1 mCi of 
(32P)Pi in the presence of actinomycin D for 2.5 h. Cells were 
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lysed at the indicated time points, and RNA preparation and 
analysis were performed as described above. 
For experiments with VSV, U937 /MxA cells were infected 
at 37°C with VSV at an MOl of 5 PFU per cell. Following 
removal of the inoculum, the cells were further incubated in 
growth medium at 37°C. At 3 h postinfection, cells were 
harvested and RNA was prepared as described by Chomc-
zynski and Sacchi (12). Experiments with cycloheximide 
(CHX) required that cells be pretreated with CHX at a 
concentration of 25 .,a.g/ml for 30 min before infection and 
kept in growth medium containing 25 J.Lg of CHX per ml for 
the duration of the whole experiment. The RNA prepara-
tions were analyzed for the presence of VSV N and L 
mRNAs by the Northem blotting technique as described 
earlier (38). The hybridization probes were the Hindiii-
EcoRI fragment of plasmid pGN2 (14), for detection of N 
mRNA, and an equimolar mixture of the 1,200- and the 
1,400-bp Pstl fragments of plasmid pLH661 (42), for detec-
tion of L mRNA. 
lmmunofluorescence and flow cytometry. For total cell 
staining, 5 x lOS cells were fixed with 3.5% formaldehyde in 
phosphate-buffered saline (PBS) for 30 min and permeabi-
lized in PBS containing 0.25% Triton X-100 for 10 min at 
room temperature. After being blocked for 15 min in washing 
buffer (PBS without Mg2+ and Ca2+, containing 0.4% bovine 
serum albumin and 0.02% sodium azide), the cells were 
incubated for 1 h with the specific antibody and, after three 
washing steps, incubated for a further hour with the second 
antibody (goat anti-mouse phycoerythrin; Dianova). All 
steps were carried out at room temperature. Cells were 
analyzed in a ftuorescence-activated cell scanner (FACScan; 
Becton Dickinson). 
For surface immunoftuorescence staining, cells were fixed 
for 5 min without permeabilization and incubated with the 
appropriate antibodies for 30 min on ice. 
Immunoprecipitation. Pulse-chase experiments were made 
with 2 x 106 cells infected with MV at an MOl of 1 for 15 h. 
Cells were starved for 30 min in methionine-free medium 
before 0.2 mCi of [35S)methionine was added. Labelling was 
performed for 3 h, and cell extracts were prepared by Iysis in 
RIPA detergent (150 mM sodium chloride, 10 mM Tris, 1% 
deoxycholic acid, 1% Triton X-100, 1% sodium lauryl sulfate 
[SDS], 10 mM phenylmethylsulfonyl ftuoride). Equal amounts 
of protein were immunoprecipitated with human hyperimmune 
serurn and separated by SDS-10% polyacrylamide gel electro-
phoresis (PAGE). Pulse-labelling of infected cells was per-
formed as described above except for an increase in the 
pulse-labelling period to 5 h. Lysates were immunoprecipitated 
with either human hyperimmune serum or a monoclonal anti-
body against the MV H protein. 
Western blot analysis. Cell extracts were prepared as 
described above in RIPA detergent. A total of 10 JJ.g of total 
cell extracts was separated on 10% PAGE and transferred to 
nitrocellulose filters with a semidry blotter. Western blots 
were immunostained with a monoclonal anti-human MxA 
antibody or an anti-human p68 antibody. A peroxidase-
conjugated rabbit anti-mouse immunoglobulin was used as 
the second antibody and developed with the enhanced 
chemiluminescence (ECL) system (Amersham). 
RESULTS 
MxA expression is not inducible in tbe human monocytic cell 
line U937. To assess the inducibility of MxA, the monocytic 
cell line U937 and the B-cell line BJAB were treated exog-
enously with 1,000 U of IFN-ß per ml or infected with MV at 
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FIG. 1. (A) Western blot analysis of celllysates (10 ~g pe-r lane) 
prepared from BJAB cells (lanes 1 to 3) and U937 cells (lanes 4 to 6). 
Cells were either kept untreated (lanes 1 and 4), stimulated with 
1,000 U of IFN-p per ml for 48 h (lanes 2 and 5), or infected with MV 
at an MOl of 1 for 48 h (lanes 3 and 6). The Western blot was 
immunostained with a monoclonal antibody against the human MxA 
protein, and the ECL system was used for detection of specific 
signals. The position of the MxA band is indicated. (B) U937 cells 
were left untreated (lane 1), stimulated with 1,000 U of IFN-a (lane 
2) or IFN-p (lane 3) per ml, infected with MV at an MOl of 1 for 48 
h (lane 4), or infected with human immunodeficiency virus at an 
MOl of 0.1 for 4 days (lane 5). A total of 10 ~g of total celllysates 
per lane was separated on a 10% polyaccylamide gel. The Western 
blot was stained with a monoclonal antibody against the IFN-
inducible p68 protein, the position of which is indicated. 
an MOl of 1 for 48 h. Whole-cell protein extracts were 
prepared and analyzed for the expression of the 78-kDa MxA 
protein by Western blotting (Fig. 1A). In BJAB cells, MxA 
was induced by both IFN-~ (Fig. 1A, lane 2) and infection 
with MV (Fig. 1A, lane 3). However, in protein extracts of 
U937 cells no MxA-specific signals could be detected (Fig. 
1A, lanes 4 to 6). In contrast to the inability to detect MxA 
protein, expression of a second IFN-inducible gene, p68, 
was clearly stimulated in U937 cells by IFN treatment (Fig. 
18, lanes 2 and 3) or viral infection (Fig. 1B, lanes 4 and 5). 
This indicates that the inability of U937 cells to express MxA 
was specific for this particular protein rather than reflecting 
a generat defect in the IFN pathway of these cells. 
Stably transfeded U937 ceUs expressing MxA protein. The 
2.0-kb Smal cDNA fragment containing the entire coding 
region for the MxA protein, but lacking 397 nucleotides of 
the 3' untranslated 450-bp sequence, was cloned into the 
multiple cloning site of plasmid pH~ APr-1-neo between the 
~-actin promoter and the polyadenylation sequence as de-
scribed in Materials and Methods. In addition, the vector 
contained a neomycin resistance gene driven by the siQ'lian 
virus 40 promoter as a selection marker. Following lipofec-
tion, stably transfected U937 cells were selected in medium 
containing G418 for a period of approximately 4 weeks, after 
which surviving cells were cloned by limiting dilution. Nine 
independent cell lines were obtained after 7 weeks and 
continuously cultured in the selection medium. The U937 
cell clones were assayed for MxA expression by immuno-
fluorescence staining and subsequent flow cytometry analy-
sis. As shown in Table 1, all clones, with the exception of 
clone 8, expressed high Ievels of MxA protein. The mean 
fluorescence intensity in these populations was comparable 
to the intensity for infected BJAB cells which were used as 
a control (data not shown). Clone 8 did not express MxA and 
was therefore used in addition to the nontransfected cellline 
as a negative control for the following experiments. Expres-
J. VIROL. 
TABLE 1. Expression of MxA protein in cloned 
U937 transfectants 
Cellline 
BJAB ............................................................ . 
U937 ............................................................. . 
U937 clones 
1 ............................................................... .. 
2 ................................................................ . 
3 ............................................................... .. 
4 ............................................................... .. 
5 ............................................................... .. 
6 ............................................................... .. 
8 ................................................................ . 
9 ............................................................... .. 
10 ............................................................. .. 
% Fluorescence-
positive cells" 
90.1 
1.7 
89.3 
89.3 
87.8 
93.8 
91.3 
93.6 
1.4 
92.5 
89.6 
" Percent ftuorescence-positive cells was estimated by ftuorescence-acti· 
vated cell scanner analysis of cells stained with a monoclonal antibody against 
the MxA protein. For negative controls, cells were stained with a nonrelated 
monoclonal antibody whose fluorescence signal was set to 0%. 
sion of MxA remained stable for all U937 /MxA clones for 
more than 1 year. 
VSV and MV multiplication in stably transfected U937/MxA 
clones. To test the biological activity of the transfected MxA 
gene, the multiplication of VSV in U937 clones expressing 
MxA was compared with that in the parental cellline. Cells 
were infected at an MOl of 10 and supematants were 
harvested after 24 h and titrated on Vero cells. In control 
cells, VSV replicated to a titer of 107 PFU/ml; however, in 
the transfectants VSV titers were reduced, indicating a 
reduction of at least 30- to 100-fold. This was comparable to 
the data described for 3T3/MxA cells (Table 2) (33). By 
repeating the experiment under the same conditions with 
MV, essentially the same results were obtained, with titers 
of infectious MV released after 48 h from U937 MxA-
expressing clones being significantly lower than those of the 
nonexpressing control cells (Table 2). 
MV -specific transcription in transfeded and nontransfected 
U937 cells. Since the inhibition of primary transcription of 
VSV genes has been described for 3T3/MxA cells (43), 
MV -specific transcription in U937 cells and the MxA-trans-
fected celllines was analyzed. Vero cells were included as 
additional controls. Cells were infected with MV at an MOl 
of 1; total RNA was prepared after 48 h and assayed for the 
expression of the monocistronic MV -specific transcripts by 
quantitative Northern blotting (Fig. 2). Signals specific for 
N-, P-, M-, F-, and H-specific monocistronic transcripts and 
the corresponding synthetic Standard RNAs were quanti-
tated, and the transcription gradients were determined in 
TABLE 2. Virus production in MxA-expressing U937 cells 
Cell 
line 
U937 
U937/5 
U937/6 
2 X lOS 
3 X lQl 
2 X lQl 
Amt of virus (PFU/ml)" 
1 X 107 
1 X lOS 
3 X lOS 
" The data result from two independent experiments. 
b A total of 1lf cells were infected with MV for 2 days at an MOl of 10 and 
cultivated in 1 ml of medium. Supernalants were analyzed in 10-fold dilutions 
on Vero cells in endpoint titration assays. 
c Cells were infected witb VSV at an MOl of 10 for 24 h. and supematants 
were analyzed as described above. 
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FIG. 2. (A) Results of the quantitative analysis of the Northern 
blots (D to E). The values are the relative expression of the MV 
genes in comparison with that of the individual N gene whose 
expression was set at 100%. (B to E) Northern blot analysis of 1 ..,.g 
of pA + RNA derived from MV-infected Vero cells (B) and of 30 ..,_g 
of total RNA from U937 (C), U937/5 (D), and U937/6 (E) cells 
infected with MV at an MOl of 1. Probes were mixed with synthetic 
standard RNAs and separated on a formaldehyde-containing 1.5% 
agarose gel. Filter strips were hybridized to 32P-labeled strand-
specific RNA probes and ordered according to the MV gene order. 
Open squares, positions of the polycistronic RNAs; closed triangles, 
positions of the monocistronic RNAs; open triangles, positions of 
the standard RNAs. 
relation to the individual N-gene transcript (N = 100%). 
Compared with Vero cells (Fig. 2A and B), untransfected 
U937 cells showed a significantly steeper transcription gra-
dient, characterized by a low abundance of all monocistronic 
MV-specific transcripts downstream of the N gene (Fig. 2A 
and C). Comparison of the amounts of MV-specific tran-
scripts in the MxA-expressing U937 clones 5 and 6 (Fig. 2D 
and E) and in untransfected control cells revealed no signif-
icant differences (Fig. 2A, C, D, and E). The same results 
were obtained with U937/MxA clone 8 as the negative 
control (data not shown). In order to exclude the possibility 
that transcriptional downregulation was missed because of 
the accumulation of viral transcripts during the 48 h of 
infection, pulse-labelling of the viral RNAs in the presence 
of (32P]Pi was performed for U937 clones 5, 6, and 8. As 
shown in Fig. 3A, considerable amounts of all MV-specific 
transcripts were produced. For clones 5 and 6 (Fig. 3A, lanes 
1 and 2), which both expressed high Ievels of MxA, again no 
differences from the control cells were observed (Fig. 3A, 
lane 3). 
To assess the stability of MV -specific transcripts, a pulse-
chase experiment was performed for MV-infected Vero, 
U937, and U937/MxA clone 5 cells (Fig. 3B). The rate of 
synthesis of MV -specific transcripts in U937 cells was gen-
erally lower than that in Vero cells during the 90-min 
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pulse-labelling period (Fig. 3B, lanes 4 and 7). No differences 
in the stability of the viral transcripts were observed for 
infected U937 /MxA transfectants (Fig. 3B, lanes 1 to 3) 
compared with U937 parental cells. We conclude from these 
experiments that the restriction observed for MV growth in 
U937/MxA cells is not due to regulation at the Ievel of RNA 
transcription or at the Ievel of mRNA stability. 
Specific Inhibition of MV glycoprotein expression in U937/ 
MxA transfectants. U937 cells and transfected U937 /MxA 
clones 5, 6, and 8 were infected with MV at an MOl of 1, and 
the expression of MV -specific structural proteins was ana-
lyzed after 48 h by indirect immunoftuorescence with mono-
clonal antibodies. The quantitative analysis was performed 
by ftow cytometry with an N-specific antibody. No signifi-
cant differences in the expression of this structural protein 
could be observed for all celllines tested. The histograms for 
U937/MxA clones 8 and 5, which are representative of all 
cell clones, are shown in Fig. 4 (Fig. 4, N). Similar results 
were obtained for the accumulation of P and M proteins 
(data not shown). In contrast, the expression of the viral 
glycoproteins F and H was significantly reduced at the 
surface of U937 /MxA cell clones 5 and 6 compared with the 
nontransfected cells and U937 /MxA clone 8, which does not 
express MxA. As an example, the immunoftuorescence 
intensity for clone 5 in comparison to clone 8 is reduced on 
average by 1log (Fig. 4, F and H). The considerably reduced 
expression of the viral glycoproteins in MxA-expressing 
U937 cells was confirmed by performing indirect immuno-
ftuorescence staining of MV F and H in permeabilized cells. 
In order to determine whether or not the restricted accu-
mulation of the glycoproteins was due to their reduced 
stability, U937 /MxA clones 5 and 8 were infected with MV at 
an MOl of 1 for 15 h, pulse-labelled with (35S]methionine for 
3 h, and subsequently chased for the time intervals indicated 
(Fig. 5). MV-specific proteins were immunoprecipitated with 
human hyperimmune serum (Fig. 5, lanes 1 to 8). As in Fig. 
4, no differences in N-protein expression between the cell 
clones were seen (Fig. 5, lanes 1 and 5), whereas the 
H-protein synthesis in U937/MxA clone 5 was reduced, in 
comparison with that in U937 /MxA clone 8, at each time 
point tested (Fig. 5). In contrast, no differences in stability 
were observed for N and H proteins in U937 clone 5 and 
clone 8 cells (Fig. 5, lanes 1 to 8). 
In order to assess differences in the rate of synthesis of 
MV glycoproteins, U937 clones 5, 6, and 8, plus the untrans-
fected U937 cells, were infected as described in the previous 
experiment. Pulse-labelling was performed for 5 h, beginning 
at 15 h postinfection, and MV -specific proteins were immu-
noprecipitated with human hyperimmune serum (Fig. 6, 
lanes 1 to 4) or a monoclonal antibody against H (Fig. 6, 
lanes 5 to 8). Precipitation with human hyperimmune serum 
against MV revealed that the synthesis of N protein was not 
significantly different in U937 clones 5 and 6 compared with 
clone 8 and the untransfected control (Fig. 6, lanes 1 to 4). In 
contrast, the synthesis of H proteinwas strongly reduced in 
clone 5 cells and less, but still somewhat, significantly 
reduced in clone 6 cells compared with the controls (Fig. 6, 
lanes 1 to 4). This finding was confirmed with the monoclonal 
anti-H antibody (Fig. 6, lanes 5 to 8). Therefore, we reinves-
tigated the MxA expression of clone 6 cells. A considerable 
loss of the mean expression Ievel of MxA was observed, 
which most probably accounted for the lesser ability to 
downregulate H protein synthesis compared with that of 
clone 5 (Fig. 6, lanes 6 and 7). 
Our data indicate that the primary target for the regulation 
of MV gene expression by MxA may be a specific inhibition 
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FIG. 3. In vivo [32P]Pi labelling of MV-specific RNAs (A). U937/6 (lane 1), U937/5 (lane 2), and U937/8 (lane 3) cells were infected with 
MV (MOl of 1) for 20 h. Cells were Iabeted with [32P]Pi for 7 hin the presence of actinomycin D. RNA was prepared, separated on a 
formaldehyde-containing 1.5% agarose gel, transferred to nitrocellulose, and analyzed by autoradiography. (B) Pulse-chase experiment to 
compare the rates of RNA degradation in the MxA-expressin~ clone U937/5 (lanes 1 to 3), the parental cellline U937 (lanes 4 to 6), and 
MV-infected Vero cells (lanes 7 to 9). Cells were Iabeted with [ 2P]Pi for 2.5 h, and RNA was prepared at the indicated time points after the 
start of the chase. Positions of the virus-specific RNAs are indicated. "Bi" means the polycistronic MV-specific RNAs. 
of viral glycoprotein synthesis, leaving the expression of 
other viral structural proteins unaffected. 
Inhibition of VSV syntbesis in U937 /MxA cells. Previous 
results demonstrated an interference of MxA protein with 
VSV mRNA synthesis in Swiss 3T3 mouse cells constitu-
tively expressing MxA ( 43). This is in contrast to the data 
presented here which indicate that the reduction of MV 
multiplication by MxA protein occurs by inhibition of viral 
glycoprotein synthesis. The following experiments were 
done to define the VSV multiplication step blocked in 
U937/MxA cells. In Western blotting experiments, a strong 
reduction of viral proteins was found for VSV -infected 
I F I N /\ 
I\ 0937/5 MV 
i \ 
I ' I \ J \ 
MV 
' ./ 
U937/MxA cells which expressed high Ievels of MxA com-
pared with control cells (data not shown). To examine RNA 
synthesis, 107 cells of the U937/MxA clones 1, 5, 6, and 9, 
and of clone 8 as a control, were infected with VSV at 5 PFU 
per cell. After 30 min at 37°C, the inoculum was removed 
and the cells were incubated in medium at 37°C. At 3 h 
postinfection, cells were harvested and RNA was prepared 
and analyzed for the presence of N and L mRNAs. As 
shown in Fig. 7 A, at least 50-fold-lower concentrations of N 
and L mRNAs were found for the clones expressing MxA at 
high Ievels (lanes 2 to 5) compared with control cells (lane 1). 
This inhibitory effect of MxA protein on both virus protein 
I H 
fluoreecence inteneity 
FIG. 4. Fluorescence-activated cell scanner analysis of virus-specific protein expression. Cells were fixed, permeabilized with Triton 
X-100, and stained with a monoclonal antibody against the N protein (N), or not permeabilized and surface stained with monoclonal antibodies 
against MV Fand H proteins (Fand H) as described in Materialsand Methods. lnfected cells of U937/MxA clone 5, stained with an unrelated 
antibody (anti-coronavirus S protein), were used as controls and are represented by the unlabelled Jines. 
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FIG. 5. Time course of virus protein degradation in MxA-ex-
pressing U937 cells. U937/5 (lanes 1 to 4) and U937/8 (lanes 5 to 8) 
cells were infected with MV (MOl of 1) ovemight and Iabelied with 
(35S]methionine for 3 h. Lysates were prepared at the indicated time 
points following chase. A total of 50 f.L8 of every lysate was 
immunoprecipitated with a human anti-MV hyperimmune serum 
and separated on a 10% polyacrylamide gel. Positions of MV N and 
H proteins are indicated. Lane 9, molecular size markers. 
and RNA accumulation could be due to direct interference 
with either VSV mRNA or protein synthesis. To distinguish 
between primary transcription of the parental viral genome 
and transcription of the amplified viral genome, which 
depends on ongoing translation, we carried out a parallel 
experiment in the presence of the protein synthesis inhibitor 
CHX. The optimal concentration of CHX to achieve minimal 
cytotoxicity with inhibition of protein synthesis by more 
than 95%, as determined by (35S]methionine incorporation, 
for our celllines was 25 ...,glml. CHX (25 J.Lg/ml) was added to 
each culture 30 min before infection, and this concentration 
was maintained throughout the experiment. As shown in 
Fig. 7B, under these conditions a pronounced reduction of N 
mRNA and an even greater reduction of L mRNA concen-
trations were found in U937/MxA clones (lanes 2 to 5) 
compared with control cells (lane 1). Thus, MxA protein 
inhibits the accumulation of primary VSV transcripts in both 
U937/MxA cells and MxA-transfected 3T3 cells and inter-
feres with different steps of viral replication of VSV and MV 
in a homologous system. 
DISCUSSION 
This study provides experimental evidence for an MxA-
dependent regulation of MV gene expression in the stably 
transfected human monocytic cell line U937. In contrast to 
findings with VSV in transfected mouse 3T3/MxA and hu-
man U937 /MxA cells, the primary target of the regulatory 
action of MxA for MV appeared to be located at the 
posttranscriptional Ievel for the expression of the virus-
specific glycoproteins. 
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FIG. 6. Immunoprecipitation of MV-specific proteins in the 
MxA-expressing U937 clones 5 (lanes 2 and 6) and 6 (lanes 3 and 7) 
in comparison with that in the original cell line (lanes 1 and 5) and 
the non-MxA-expressing clone 8 (lanes 4 and 8). Cells were Iabeiied 
with ess]methionine after overnight infection for 5 h. Lysates were 
prepared and immunoprecipitated with either an anti-MV hyperim-
mune serum (lanes 1 to 4) or a monoclonal antibody against the MV 
H protein (lanes 5 to 8). Positions of the MV N and H proteins are 
indicated. Lane 9, molecular size markers. 
The mechanism for the obsetved restriction of viral gly-
coprotein expression appeared to act on steps later than 
transcription, because it was shown that synthesis and 
stability of the corresponding mRNAs were unaffected (Fig. 
2 and 3). Unfortunately, the translational activity of these 
mRNAs could not be tested in vitro. First, the corresponding 
mRNAs are expressed to relatively low copy numbers, and 
second, the proteins synthesized in vitro are not detected 
because the glycoprotein-specific antiborlies are directed 
against the glycosylated protein. The possibility that MxA 
interferes with the processing of the mRNAs for F and H is 
unlikely since comparable amounts of H protein were de-
tected in both U937/MxA cells and the control cells by 
short-time-labelling experiments (Fig. 5). In addition, it is 
difficult to envisage that defects in mRNA maturation would 
be selective for F- and H-specific transcripts alone. For the 
same reason, alterations of the secondary structure that 
might impair the translational efficiency (23) are not antici-
pated. Whereas for the F-specific mRNA secondary struc-
tures were proposed because of the 582-nucleotide-long 5' 
nontranslated region (35), the H mRNA does not differ from 
the other MV -specific mRNAs in having just a few nucle-
otides preceding the coding region (2). However, it is re-
markable to note in this context that specific translational 
inhibition of MV M and F mRNAs has been described with 
elevation of the temperature (28, 29). 
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FIG. 7. (A and B) lnhibitory effect of MxA protein on accumu· 
lation of VSV RNAs in the absence (A) and presence (B) of 25 ~g of 
CHX per ml. A total of 107 cells of U937 clones 1, 5, 6, and 9 (lanes 
2 to 5) and clone 8 as a control (lanes 1) were infected at 37°C with 
5 PFU of VSV per cell in medium containing 2% fetal calf serum. 
The inoculum was removed after 30 min, and the cells were 
incubated in medium at 37°C foranother 3 h. Subsequently, cells 
were harvested and total RNA was isolated and analyzed for the 
presence of VSV N mRNA and L mRNA by the Northem blotting 
technique (5 ~g of RNA per lane in panel A and 20 ~g of RNA per 
lane in panel B). The hybridization probes were the Hindiii·EcoRI 
fragrnent of plasmid pGN2 for detection of N mRNA and an 
equimolar mixture of the 1,200· and the 1,4QO.bp Pstl fragrnents of 
plasmid pLH661 for detection of L mRNA. 
The finding that the antiviral activity of Mx proteins can be 
posttranscriptional is not unprecedented (26, 32). In stably 
MxA·transfected 3T3 cells, the multiplication of inftuenza A 
virus proved to be inhibited at a stage later than primary 
transcription. Maturation and transport of the primary tran-
scripts were unaffected. In that study, the inhibition of viral 
protein expression was highly pronounced for the larger 
structural proteins whereas the synthesis of M and NS was 
merely affected (32). Because of the fact that most of the 
MV -specific structural proteins, except M and L, are of 
comparable sizes, it is difficult to relate the translational 
restrictions to the size of the corresponding proteins. Al-
though we were unable to determine the expression of L 
protein, because of its low expression Ievels and the Iack of 
appropriate antibodies, we would not expect this protein to 
be reduced because transcription of MV -specific mRNAs 
appeared unaltered qualitatively and quantitatively in MxA-
expressing U937 cells. 
Our data indicate that the antiviral effect on VSV replica-
tion by MxA in U937 cells was directed at the Ievel of viral 
RNA synthesis. As described previously for mouse 31'3/ 
MxA cells (43), synthesis of VSV primary transcripts was 
severely inhibited in U937/MxA cells (Fig. 7). Consequently, 
VSV proteins accumulated to Ievels barely detectable in 
U937/MxA cells (data not shown). However, it cannot be 
ruled out that an additional translational regulation may be 
imposed on these mRNAs. 
Our data confirm that the MxA-dependent inhibition of 
VSV synthesis in 3T3 and U937 cells is independent of the 
host cell. However, the inhibitory activity of MxA in human 
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U937 cells is clearly virus specific. At present, this discrep· 
ancy cannot be explained since the mode of action of Mx 
proteins has not been defined on a molecular Ievel. The 
GTPase activity of Mx proteins appears to be directly 
correlated with their antiviral activity (31). In addition, since 
they do not have RNA or DNA binding activities, Mx 
proteins may act via direct protein·protein interactions (16). 
The inhibitory effect of Mx1 on inftuenza A virus multipli· 
cation could be partially titrated by the overexpression of 
PB2. However, a direct interaction of Mx proteins with viral 
components could not be found (18). Alternatively, weak 
physical interactions of MxA protein with actin and tubulin, 
both components of the cytoskeleton, have been demon· 
strated (17). In this context, it is interesting to note that the 
association of mRNAs with the cytoskeletal framework has 
been show to play a role in governing translation of viral as 
weil as cellular mRNAs (10). Since translation of mRNA 
coding for glycoproteins requires specialized cellular com· 
partments, one could envisage that MxA in U937 cells might 
act by interfering specifically with transport of MV RNAs to, 
or their translation at, the rough endoplasmic reticulum. A 
general effect on the expression of cellular surface proteins 
cannot be overlooked but was not detected in our experi-
ments (data not shown). 
In our experimental system, the human monocytic cellline 
U937 does not express endogenaus MxA. Although the 
general pathway for IFN stimulation did not appear to be 
defective (Fig. 1B), it has been shown that in vivo mono· 
cytes exhibit very high Ievels of MxA, up to eightfold higher 
than those in T or B cells, upon exogenaus IFN treatment 
(16). During acute infection, MV infects predominantly 
PBMCs accompanied by the production of type I IFN (19, 
34). Type I IFN, as weil as MV infection, also Ieads to the 
induction of MxA in PBMCs in vitro. Because of the 
inhibitory action of MxA an MV glycoprotein synthesis, a 
powerful mechanism is provided for the establishment of a 
persistent infection in monocytic cells by a direct interfer-
ence with virus replication in MxA-expressing cells, accom-
panied by a reduction in the release of infectious virus. As 
shown by our experiments, this effect is directly dependent 
on the expression of MxA rather than additional IFN-
inducible proteins, since comparable amounts of IFN are 
induced in MxA-expressing and nonexpressing U937 cells 
following MV infection, as indicate9 by the expression of 
p68 (Fig. 1B). In addition, following exogenaus IFN treat-
ment, no synergistic effects on the inhibition of MV replica-
tion in either cell type could be observed (data not shown). 
MV is the causative agent of subacute sclerosing panen-
cephalitis and measles inclusion body encephalitis. In both 
diseases, the occurring MV persistence in brain cells is 
characterized by particular transcriptional and translational 
defects (7, 41). It has been observed that, during the estab-
lishment of persistent MV infections, factors intrinsic to the 
neural cells provide regulatory mechanisms restricting viral 
gene expression (4, 39)~ Among those, transcriptional down-
regulation leading to steep transcription gradients for the 
monocistronic MV-specific mRNAs has been described (39, 
40). In accordance with those findings, we have observed a 
similar transcription pattern in primary infected monocytic 
U937 cells (Fig. 2). Transcriptional downregulation of MV-
specific mRNAs tagether with an MxA-dependent specific 
inhibition of glycoprotein expression renders monocytes 
prime candidates for the establishment of persistent MV 
infections in PBMCs. Further experiments will help in the 
elucidation of the molecular mechanisms underlying these 
particular cell-type-specific regulations of MV. 
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